Filter
2681
Filtered Results: 2681
Text search:
hépatite
Featured
Recommendations
297
New Publications
742
Language
Document type
No document type
1630
Guidelines
432
Studies & Reports
288
Manuals
119
Strategic & Response Plan
82
Fact sheets
45
Training Material
32
Situation Updates
22
Resource Platforms
11
Infographics
9
Brochures
5
Videos
3
Online Courses
2
App
1
Countries / Regions
India
157
Western and Central Europe
73
Germany
72
Global
69
Kenya
54
Nepal
49
South Africa
47
Latin America and the Carribbean
43
Nigeria
41
Bangladesh
40
Sierra Leone
37
Paraguay
36
Liberia
36
Tanzania
35
Indonesia
35
Argentina
34
Zambia
33
Uganda
32
Myanmar / Burma
32
Ethiopia
31
Ukraine
29
Venezuela
29
Eastern Europe
28
Colombia
27
Ghana
25
Rwanda
25
Philippines
25
Brazil
23
Mozambique
22
Malawi
21
Africa
18
Namibia
18
Lesotho
17
Russia
17
Syria
16
South–East Asia Region
16
Asia
15
Bolivia
11
Zimbabwe
10
Botswana
10
Eswatini/ Swaziland
10
Albania
9
Pakistan
9
Congo, Democratic Republic of
8
Georgia
8
South Sudan
8
Burkina Faso
7
Peru
7
Guinea
7
Cambodia
7
East and Southern Africa
7
El Salvador
6
Senegal
6
Haiti
6
Middle East and North Africa
6
Western Pacific Region
6
Armenia
5
Lebanon
5
Moldova
5
North Macedonia
4
Tajikistan
4
Mexico
4
Cameroon
4
Afghanistan
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Papua New Guinea
4
Ecuador
4
Switzerland
3
Timor Leste/ East Timor
3
Togo
3
Chile
3
Laos
3
Sudan
3
Central African Republic
3
Angola
3
Thailand
2
Turkey
2
Iran
2
Estonia
2
USA
2
Hungary
2
Jordan
2
Saudi Arabia
2
Portugal
2
Vietnam
2
Egypt
2
Yemen
2
Poland
2
Libya
2
Bhutan
2
Iraq
2
Somalia
2
Serbia
1
Gambia
1
China
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Qatar
1
Dominican Republic
1
Guinea-Bissau
1
Uruguay
1
Jamaica
1
Mauritius
1
United Kingdom
1
Norway
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Sri Lanka
1
Djibouti
1
Romania
1
Palestine
1
Mali
1
Chad
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1009
Clinical Guidelines
290
Key Resources
137
Women & Child Health
121
Public Health
91
Pharmacy & Technologies
41
Capacity Building
36
Annual Report MEDBOX
1
Toolboxes
HIV
469
TB
245
COVID-19
132
Refugee
126
Mental Health
113
Pharmacy
76
NTDs
71
Rapid Response
66
Ebola & Marburg
62
Caregiver
57
Conflict
46
AMR
40
Global Health Education
33
Natural Hazards
32
Planetary Health
30
NCDs
22
Zika
13
Polio
11
Cholera
10
Disability
8
Health Financing Toolbox
8
Specific Hazards
3
South Sudan
1
WHO’s Dr Philippa Easterbrook gives a situation update on the recent hepatitis outbreak affecting children including possible causes and steps parents, caregivers and countries should take.
An overview of validation structures and responsibilities at national, regional and global levels.
This governance document supplements the global guidance document. Validation of elimination requires rigorous assessment at the national, regional and global levels of the impact and process indicato...
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios
Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático,...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
Updated recommendations on simplified service delivery and diagnostics for hepatitis C infection
recommended
Policy Brief. 24 June 2022. This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public health approach to HCV testing, care and treatment. These recommendations include decentralization, integration and ta...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
Viral hepatitis is defined as inflammation of the liver cells due to viral infection. The burden of liver disease in South Africa is mostly underestimated as viral hepatitis, in particular chronic infection, is a silent and neglected cause of morbidity and mortality. However, the burden of disease i...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
L’objectif des lignes directrices 2024 est de fournir des recommandations actualisées et fondées sur
des données probantes sur les principaux sujets prioritaires. Ceux-ci concernent notamment les critères élargis et simplifiés de mise sous traitement pour les adultes, mais aussi désormais ...
With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable an...
